Sign In
Learn bits
Health & Medicine
Pradeep Kumar

09/05/21 09:20 AM IST

Anti-COVID drug developed by DRDO

In news

An anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO)

About the drug
  • The drug comes in powder form in a sachet and is taken orally by dissolving it in water.
  • It accumulates in the virus-infected cells and prevents virus growth by stopping viral synthesis and energy production.
  • Its selective accumulation in virally infected cells makes this drug unique.
  • Clinical trial results of the drug have shown that it helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence.
  • A higher proportion of patients treated with 2-DG showed RT-PCR negative conversion in COVID patients.
Source: PIB, The Hindu

More Related Current Affairs View All

28 Aug

IADT-1

'Recently, the Indian Space Research Organisation (ISRO) successfully carried out its first Integrated Air Drop Test (IADT-1), a crucial milestone in the preparation for the countr

Read More

28 Aug

H-1B visa changes

'H-1B visa changes 2025: United States Commerce Secretary Howard Lutnick called the popular H-1B visa program a “scam”, saying that American businesses should be focuse

Read More

28 Aug

UGC’s Learning Outcomes-based Curriculum Framework

'Recently, the University Grants Commission (UGC) issued a public notice on its development of a draft Learning Outcomes-based Curriculum Framework (LOCF).' LOCF is intended to

Read More

India’s First Ai-Driven Magazine Generator

Generate Your Custom Current Affairs Magazine using our AI in just 3 steps